Optimizing Use of DMI Fungicides for Management of Apple Powdery Mildew Caused by Podosphaera leucotricha in New York State

Plant Disease ◽  
2021 ◽  
Author(s):  
David Strickland ◽  
Sara M. Villani ◽  
Kerik Cox

Powdery mildew, caused by the ascomycete Podosphaera leucotricha, is an endemic disease found wherever apples are grown that negatively impacts both tree vigor and fresh market yield. In the absence of durable host resistance, chemical management is the primary means of disease control. Demethylation inhibitor (DMI) fungicides are widely used to manage apple powdery mildew, but members within this fungicide class have been observed to differ in efficacy with respect to disease control. Moreover, debate exists as to the optimal timing of DMI fungicide applications for management of apple powdery mildew. In this regard, the goal of this study was to determine the best-use practices for DMI fungicides to manage apple powdery mildew in New York State. Multi-year trials were conducted to evaluate the potential differential efficacy performance of four common DMI fungicides, as well as additional trials to assess optimal application timing. In all years, we observed that treatments of flutriafol and myclobutanil consistently had the lowest incidences of powdery mildew compared to difenoconazole and fenbuconazole. In the 2018 and 2021 trials, the newly registered mefentrifluconazole was more comparable to the difenoconazole program with respect to powdery mildew disease incidence. We hypothesize that differences in DMI efficacy may be due to each fungicides’ water solubility and lipophilicity characteristics, and thus their ability to move systemically in the host or more easily penetrate the surface of germinating conidia. Applications timed between petal fall and first cover resulted in the lowest incidence of powdery mildew on terminal leaves of apple shoots compared to applications timed prior to petal fall. These observations are contrary to previous studies conducted in regions with differing climates. We also found that the incidence of secondary powdery mildew observed two weeks after petal fall was influenced by applications of DMI fungicides during the previous season. For example, management programs consisting of applications of flutriafol or myclobutanil in the prior season tended to have lower incidence of apple powdery in the following spring, presumably owing to reductions in overwintering inoculum. Despite reports of DMI resistance in other apple pathosystems, the DMI fungicide class is still relevant for the successful management of apple powdery mildew in New York State.

PEDIATRICS ◽  
1956 ◽  
Vol 18 (3) ◽  
pp. 506-508

APPEARANCE of "new diseases" is a phenomenon well known to observing pediatricians. When a new disease is first reported, there is often some doubt as to whether it is a separate entity, then a certain amount of hesitation while the definition and characteristics of the disease are being investigated, and finally a rush of increased diagnoses as the disease becomes more "popular" or is better understood. Very often therapy awaits elucidation of etiology, and, of course, therapy is not always successful. The problem of retrolental fibroplasia has constituted an interesting case in point which, while it has not followed all of the characteristics noted above, has certainly approached them. A recently published analysis of "The Rise and Fall of Retrolental Fibroplasia in New York State—A Preliminary Report" by Yankauer, Jacobziner, and Schneider (New York State J. Med., 56:1474, May 1, 1956), reviews in striking fashion the progress of the disease. In contrast to many reports of disease incidence, the paper from New York State is a model of care and precision. The authors point out that diagnosis and follow-up of this condition in New York State are encouraged by state laws regarding the care of the blind, as well as by the special programs for premature infants, which have been promoted by both the city and the state health departments. Furthermore, the reports on the disease have been carefully investigated and the fact of "popularity" mitigated by studying both the time at which the disease is reported in relation to the age of the child, and the evidence for confirmation of the diagnosis.


2012 ◽  
Vol 15 (3) ◽  
pp. 222-228 ◽  
Author(s):  
Ying Wang ◽  
Joseph Kennedy ◽  
Michele Caggana ◽  
Regina Zimmerman ◽  
Sanil Thomas ◽  
...  

Author(s):  
Marvin S. Swartz ◽  
Jeffrey W. Swanson ◽  
Henry J. Steadman ◽  
Pamela Clark Robbins ◽  
John Monahan

Sign in / Sign up

Export Citation Format

Share Document